Complete Genomics (GNOM) Posts Narrower than Expected Q1 Loss

Complete Genomics, Inc. (NASDAQ: GNOM) reported Q1 EPS of ($0.60), $0.02 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $3.91 million versus the consensus estimate of $4.84 million.

For earnings history and earnings-related data on Complete Genomics, Inc. (GNOM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nebius soars on second quarter revenue beat
• LiqTech International (LIQT) Reports In-Line Q2 EPS
• Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c